Back
Compare AU
Compare QOZ vs. CNEW
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Betashares FTSE Rafi Australia 200 ETF (QOZ) and the VanEck China New Economy ETF (CNEW). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
QOZ | CNEW | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 85 | 66 |
Median incremental investment | $1,196.50 | $829.73 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,935.92 | $1,911.18 |
Average age group | > 35 | > 35 |
Key Summary
QOZ | CNEW | |
|---|---|---|
Strategy | QOZ.AX was created on 2013-07-10 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The investment objective of the BetaShares FTSE RAFI Australia 200 ETF is to provide an investment return that tracks the performance of the FTSE RAFI Australia 200 Index (the Index), before taking into account fees and expenses. | CNEW.AX was created on 2018-11-08 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 104.46m in AUM and 122 holdings. CNEW.AX gives investors a portfolio of the most fundamentally sound companies in China having the best growth prospects in sectors making up the New Economy, namely technology, health care, consumer staples and consumer discretionary. CNEW.AX aims to provide investment returns, before fees and other costs, which track the performance of the Index. |
Top 3 holdings | SPI 200 FUTURES SEP26 (0 %) BHP GROUP LTD (13.79 %) COMMONWEALTH BANK OF AUSTRALIA (6.82 %) | Suzhou Zelgen Biopharmaceuticals Co Ltd Class A (1.31 %) Shanghai Allist Pharmaceuticals Co Ltd Class A (1.19 %) Haisco Pharmaceutical Group Co Ltd Class A (1.19 %) |
Top 3 industries | Financials (31.95 %) Materials (24.29 %) Energy (7.33 %) | Information Technology (33.78 %) Health Care (27.01 %) Consumer Discretionary (20.43 %) |
Top 3 countries | Australia (92.20 %) United States (6.36 %) United Kingdom of Great Britain and Northern Ireland (0.94 %) | China (100.00 %) |
Management fee | 0.4 % | 0.95 % |
Key Summary
QOZ | CNEW | |
|---|---|---|
Issuer | BetaShares | VanEck |
Tracking index | FTSE RAFI Australia 200 Index - AUD | CSI MarketGrader China New Economy Index - CNY |
Asset class | ETF | ETF |
Management fee | 0.4 % | 0.95 % |
Price | $18.82 | $8.15 |
Size | $1.257 billion | $100.985 million |
10Y return | 66.11 % | N/A |
Annual distribution yield (5Y) | 5.22 % | 1.33 % |
Market | ASX | ASX |
First listed date | 11/07/2013 | 09/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
QOZ | CNEW | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 85 | 66 |
Median incremental investment | $1,196.50 | $829.73 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,935.92 | $1,911.18 |
Average age group | > 35 | > 35 |
Pros and Cons
QOZ | CNEW | |
|---|---|---|
Pros |
| |
Cons |
|
QOZ | CNEW |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |